THE GENERIC DRUG BUSINESS IS BIG IN THE UNITED STATES. NOW, NEW MEXICO AND 45 OTHER STATES ARE HOPING TO GO AFTER 18 DRUG COMPANIES, ACCUSING THEM OF FIXING PRICES ON 15 GENERIC DRUGS.
ATTORNEY GENERAL HECTOR BALDERAS SAYS THE COMPANIES ARE “REAPING RECORD PROFITS BY MANIPULATING THE PRICES” OF THE DRUGS THEY MANUFACTURE AND SELL. THE INVESTIGATION INTO THE ALLEGED PRICE-FIXING BEGAN IN 2014. THE COURT IS NOW BEING ASKED TO EXPAND THE LAWSUIT TO INCLUDE 18 DRUG COMPANIES.
